Suchergebnisse

On 2 March 2016, the workshop "Salmonella - a complex topic in human and veterinary medicine" took place in Berlin with representatives from science and the Public Veterinary and Health Service (ÖGD). The event was initiated by the Academy for Public Health Düsseldorf and the National Research Platform for Zoonoses in order to enter into a dialogue between research and practice on the basis of a concrete topic. With almost 60 participants the event was completely booked out. The composition of the group of participants from various institutes and offices led to detailed discussions after each

On November 29, 2016, representatives from science and the public health service (ÖGD) met for the fourth time in Berlin at a workshop jointly organized by the National Research Platform for Zoonoses and the Academy for Public Health Düsseldorf to discuss current issues and search for possible solutions. This time, the topic was antibiotic resistance, a pressing issue that can only be solved jointly by human and veterinary medicine. Access versus Excess – globale Unterschiede in der Antibiotika-Verfügbarkeit The event was introduced by a lecture by Dr. Tim Eckmanns from the Robert Koch

In the period from 26-28 April 2017, scientists met in Berlin on the premises of the Federal Institute for Risk Assessment (BfR) to present and discuss the research results of the two consortia on antibiotic resistance RESET and MedVet-Staph, which have been funded since 2010. The event was aimed at the public, experts (including human and veterinary medicine, microbiology, epidemiology), the Public Health and Veterinary Service (ÖGD) and ministries. On the first day of the event, the results were presented in lectures and a press conference, focusing on the consequences for the Public Health

Global Health: Epidemics require global solutions Whether Ebola, West Nile, cicavirus or multi-resistant germs - epidemics cannot be stopped by national borders. How best to research, observe and contain them was discussed by around 350 scientists from human and veterinary medicine, epidemiology, bioinformatics and basic research in Berlin from 17 to 19 October 2018. "Global health is a major topic for research and politics, because global health risks from pandemics are highly topical in times of globalization," said Prof. Dr. Christian Drosten of Charité - Universitätsmedizin Berlin at the

In cooperation between the Academy for Public Health in Düsseldorf and the National Research Platform for Zoonoses, numerous representatives from science and the public health service (ÖGD) met again in Düsseldorf on 14 February 2017. The topic of this event was tuberculosis. In contrast to other regions of the world, the spread of tuberculosis in Germany has declined sharply in recent decades. The newly emerging challenges posed by resistant tuberculosis strains and global networking therefore require not only an exchange between human and veterinary medicine and between science and the ÖGD

Part 1: the West Nile virus in human medicine The West Nile virus belongs to the flaviviruses and occurs in many different regions of the world. The virus is transmitted by different mosquito species. Areas with a high incidence of West Nile virus are mainly located in tropical and subtropical areas. However, now the first human cases of West Nile virus were reported in Germany. Prof. Dr. Jonas Schmidt-Chanasit investigates with his working group at the Bernhard-Nocht-Institute for Tropical Medicine in Hamburg different mosquito-transmitted viruses, called arboviruses. Since the West Nile

Teil 2: The West Nile Virus – also a threat to animal health The West Nile virus is a mosquito-transmitted zoonotic pathogen, which was first isolated in Africa in the 1930s. In recent decades, the virus has spread to many regions of the world. By now, it has also reached Germany. Since 2018 there have been the first confirmed cases of West Nile virus in Germany. In 2019 the first infections were confirmed in humans in Germany. In the first part of our interview series we spoke to Prof. Jonas Schmidt-Chanasit of the Bernhard-Nocht-Institute for Tropical Medicine in Hamburg, who answered